Marten Steen - Profile and Investment Details

Investor Profile

Marten Steen is a Venture Capital, Private Equity Firm based in Stockholm County, Sweden with a diverse investment portfolio that includes companies such as Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG, Renovis, Aprea, Immune Targeting Systems, Glionova, LTB4 Sweden, ChemoCentryx, Oncos Therapeutics, Gyros, PTC Therapeutics, Precirix, Renovo, Hybrigenics, GenSight BiologicsOraPharma Inc. (acquired by JNJ), Pulmonx, Cardoz, Biolipox, InCarda Therapeutics, Jerini, Orexo, Nexstim, Five Prime Therapeutics, BeneChill, Hemab Therapeutics, Modus Therapeutics, Wilson Therapeutics, Algeta, BioStratum, Alba Therapeutics, Aro Biotherapeutics, Kivu Bioscience, Mahzi Therapeutics, Carisma Therapeutics, Actelion Pharmaceuticals, Idea, Pharmion, Strongbridge Biopharma, CoreValve, Dynavax Technologies, SpineVision, Ultragenyx Pharmaceutical, FerroKin Biosciences, Resistentia Pharmaceuticals, Cytos, Doctrin, Rainier Therapeutics, Sopherion Therapeutics, Lumavita, Oncorena, Tisbury Pharmaceuticals, Nucleonics, Vivet Therapeutics, Altimmune, Fusion Pharmaceuticals, Merck Serono, Bionaut Pharmaceuticals, OxThera, Tengion, . Over time, Marten Steen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Marten Steen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Finance, Software, Biotechnology, Medical Devices, Precision Medicine, Clinical Trials, Gene Therapy, Personalized Medicine, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Therapeutics, Pharmaceuticals, Service Industry, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Marten Steen, as their portfolio suggests a familiarity and interest in this area.

Understanding Marten Steen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.